Therefore, the findings of this study demonstrated that the elimination of CD56 in human ccRCC 786-O cells effectively suppressed theirs in vitro and in vivo proliferation, migration, and invasion capabilities. This evidence concerns the gene NCAM1 and nonpapillary renal cell carcinoma.